AstraZeneca
A Director role at Alexion, Astrazeneca Rare Disease, focused on developing and executing global value, access, and pricing strategies for Eneboparatide and hypoparathyroidism therapies across key markets. The role involves shaping strategies, influencing clinical development, and supporting market access and pricing decisions.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Pricing & Access Lead, Endocrinology
American Association of Physicists in Medicine
Director, Market Access, UK
argenx
Global Pricing & Market Access Lead
alnylam
Senior Director, US Market Access
Mirum Pharmaceuticals
Senior Director, Metabolic Market Access Strategy & Marketing
Travere Therapeutics
Executive Director, Global Value, Access and Pricing, NSCLC
Revolution Medicines